An updated meta-analysis on the relationship between D-dimer levels and severity of coronavirus disease 2019.
作者信息
Shi Li, Wang Ying, Wang Yadong, Duan Guangcai, Yang Haiyan
机构信息
Department of Epidemiology, School of Public Health, Zhengzhou University, Zhengzhou, China.
Department of Toxicology, Henan Center for Disease Control and Prevention, Zhengzhou, China.
出版信息
Int J Lab Hematol. 2020 Oct;42(5):e207-e210. doi: 10.1111/ijlh.13268. Epub 2020 Jun 18.
Abstract
摘要
相似文献
1
An updated meta-analysis on the relationship between D-dimer levels and severity of coronavirus disease 2019.关于D-二聚体水平与2019冠状病毒病严重程度之间关系的最新荟萃分析。
Int J Lab Hematol. 2020 Oct;42(5):e207-e210. doi: 10.1111/ijlh.13268. Epub 2020 Jun 18.
2
High incidence of stroke in COVID-19 patients.新冠病毒肺炎患者中风的高发病率。
Aging (Albany NY). 2020 Nov 20;12(22):22390-22398. doi: 10.18632/aging.104092.
3
The value of clinical parameters in predicting the severity of COVID-19.临床参数在预测 COVID-19 严重程度中的价值。
J Med Virol. 2020 Oct;92(10):2188-2192. doi: 10.1002/jmv.26031. Epub 2020 Jun 2.
4
D-dimer levels and COVID-19 severity: Systematic Review and Meta-Analysis.D-二聚体水平与 COVID-19 严重程度：系统评价和荟萃分析。
Tuberk Toraks. 2020 Dec;68(4):353-360. doi: 10.5578/tt.70351.
5
Diabetes, D-dimer and COVID-19: The possible role of glucose control.糖尿病、D-二聚体与2019冠状病毒病：血糖控制的潜在作用
Diabetes Metab Syndr. 2020 Nov-Dec;14(6):1987. doi: 10.1016/j.dsx.2020.10.011. Epub 2020 Oct 15.
6
Prevalence and Outcomes of D-Dimer Elevation in Hospitalized Patients With COVID-19.COVID-19 住院患者 D-二聚体升高的患病率和结局。
Arterioscler Thromb Vasc Biol. 2020 Oct;40(10):2539-2547. doi: 10.1161/ATVBAHA.120.314872. Epub 2020 Aug 25.
7
D-dimer level in COVID-19 infection: a systematic review.新型冠状病毒感染患者 D-二聚体水平：系统评价。
Expert Rev Hematol. 2020 Nov;13(11):1265-1275. doi: 10.1080/17474086.2020.1831383. Epub 2020 Oct 12.
8
Elevated fibrinogen and fibrin degradation product are associated with poor outcome in COVID-19 patients: A meta-analysis.纤维蛋白原和纤维蛋白降解产物升高与COVID-19患者的不良预后相关：一项荟萃分析。
Clin Hemorheol Microcirc. 2021;77(2):221-231. doi: 10.3233/CH-200978.
9
The role of D-dimer in relation to the clinical course of patients with COVID-19.D-二聚体在新型冠状病毒肺炎患者临床病程中的作用。
Acta Biochim Biophys Sin (Shanghai). 2021 Jan 12;53(1):119-120. doi: 10.1093/abbs/gmaa140.
10
Pulmonary thromboembolic disease in COVID-19 patients on CT pulmonary angiography - Prevalence, pattern of disease and relationship to D-dimer.COVID-19 患者 CT 肺动脉造影中的肺血栓栓塞性疾病-患病率、疾病模式及与 D-二聚体的关系。
Eur J Radiol. 2020 Nov;132:109336. doi: 10.1016/j.ejrad.2020.109336. Epub 2020 Oct 6.
引用本文的文献
1
Clinical Characteristics, Risk Factors for Severity and Pharmacotherapy in Hospitalized COVID-19 Patients in the United Arab Emirates.阿拉伯联合酋长国住院COVID-19患者的临床特征、严重程度危险因素及药物治疗
J Clin Med. 2022 Apr 26;11(9):2439. doi: 10.3390/jcm11092439.
2
Harmonized D-dimer levels upon admission for prognosis of COVID-19 severity: Results from a Spanish multicenter registry (BIOCOVID-Spain study).入院时统一的 D-二聚体水平对 COVID-19 严重程度的预后预测作用：来自西班牙多中心登记研究（BIOCOVID-Spain 研究）的结果。
J Thromb Thrombolysis. 2022 Jan;53(1):103-112. doi: 10.1007/s11239-021-02527-y. Epub 2021 Jul 16.
3
Early changes in laboratory parameters are predictors of mortality and ICU admission in patients with COVID-19: a systematic review and meta-analysis.早期实验室参数变化可预测 COVID-19 患者的死亡率和 ICU 入住率：系统评价和荟萃分析。
Med Microbiol Immunol. 2021 Feb;210(1):33-47. doi: 10.1007/s00430-020-00696-w. Epub 2020 Nov 21.
本文引用的文献
1
D-dimer is Associated with Severity of Coronavirus Disease 2019: A Pooled Analysis.D-二聚体与2019冠状病毒病的严重程度相关：一项汇总分析。
Thromb Haemost. 2020 May;120(5):876-878. doi: 10.1055/s-0040-1709650. Epub 2020 Apr 3.
2
Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection.慢性肾脏病与2019冠状病毒病（COVID-19）严重感染相关。
Int Urol Nephrol. 2020 Jun;52(6):1193-1194. doi: 10.1007/s11255-020-02451-9. Epub 2020 Mar 28.
3
Prominent changes in blood coagulation of patients with SARS-CoV-2 infection.SARS-CoV-2 感染患者凝血功能的显著变化。
Clin Chem Lab Med. 2020 Jun 25;58(7):1116-1120. doi: 10.1515/cclm-2020-0188.
4
Laboratory abnormalities in patients with COVID-2019 infection.2019冠状病毒病感染患者的实验室异常情况。
Clin Chem Lab Med. 2020 Jun 25;58(7):1131-1134. doi: 10.1515/cclm-2020-0198.
5
Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range.根据样本量、中位数、极差和/或四分位数间距估算样本均值和标准差。
BMC Med Res Methodol. 2014 Dec 19;14:135. doi: 10.1186/1471-2288-14-135.
6
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.系统评价与Meta分析的首选报告项目：PRISMA声明
Int J Surg. 2010;8(5):336-41. doi: 10.1016/j.ijsu.2010.02.007. Epub 2010 Feb 18.
7
Systems to rate the strength of scientific evidence.科学证据强度评级系统。
Evid Rep Technol Assess (Summ). 2002 Mar(47):1-11.
Zotero 插件